Comparison of patients who meet criteria for surgical stabilization of rib fractures versus those who actually get rib fixation: A single center review

被引:0
|
作者
Bauman, Zachary M. [1 ]
Khan, Hason [1 ]
Phillips, Jakob [1 ]
Wells, Alyssa [1 ]
Evans, Charity H. [1 ]
Liu, John L. [1 ]
Kamien, Andrew [1 ]
Cemaj, Samuel [1 ]
Sheppard, Olabisi [1 ]
Lamb, Gina [1 ]
Veatch, Jessica [1 ]
Nguyen, Jonathan [2 ]
Matos, Mike [1 ]
Cantrell, Emily [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Div Trauma Emergency Gen Surg & Crit Care Surg, 983280 Nebraska Med Ctr, Omaha, NE 68198 USA
[2] Grady Mem Hosp, Div Acute Care Surg, Dept Surg, Atlanta, GA 30303 USA
关键词
Surgical stabilization of rib fractures; Rib fractures; Contraindications; Indications; Incidence; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; OPERATIVE FIXATION; FLAIL CHEST; TRAUMA; MANAGEMENT; ASSOCIATION; SURGERY;
D O I
10.1016/j.injury.2024.111930
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Surgical stabilization of rib fractures (SSRF) has shown benefits for rib fracture patients. However, the incidence of SSRF performed remains low. We compare our institution's rib fracture patients meeting criteria for SSRF versus those actually receiving the operation, hypothesizing a significant portion are not undergoing SSRF. Methods: A retrospective review of rib fracture patients presenting to our Level 1 trauma center from 1/2016 to 4/2023. Patients were categorized as those who met SSRF inclusion criteria versus those who didn't based on the 2023 Chest Wall Injury Society (CWIS) SSRF Guidelines. Basic demographics were obtained. Patients meeting SSRF criteria were divided into those who received SSRF versus those who didn't. Outcomes of interest included type and frequency of SSRF indications and frequency of absolute/relative contraindications. Descriptive statistics were used. Median test and t-test were used for statistical analysis. Statistical significance was set at p < 0.05. Results: A total of 3,432 patients presented with >= 1 rib fracture(s). Of those, 1,573(45.8 %) met SSRF inclusion criteria. These patients were predominantly male, with mean age of 57.4(+/- 18.5) and a similar Injury Severity Score but significantly higher chest-Abbreviated Injury Score of 3 (Interquartile range 3,4)(p = 0.048). Only 458 (29.1 %) patients underwent SSRF, leaving 1,115(70.9 %) managed non-operatively, of which 215(19.3 %) were ventilated and "failure to wean from the ventilator" was the most common (81.4 %) indication for SSRF. Of the 900(80.7 %) non-ventilated patients managed non-operatively, 659 (69.9 %) had >= two indications for SSRF, 382 (34.3 %) had zero relative contraindications and 394(35.3 %) had one relative contraindication for SSRF. Lastly, 52.6 % of patients in this cohort had reported "clicking/popping" of their fractures. Conclusion: Only 29.1 % of patients meeting criteria for SSRF had the operation based on data from our institution. There may be additional opportunity to benefit this cohort of patients meeting SSRF criteria but not undergoing surgery.
引用
收藏
页数:6
相关论文
共 29 条
  • [11] Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI)
    Prins, Jonne T. H.
    Van Lieshout, Esther M. M.
    Ali-Osman, Francis
    Bauman, Zachary M.
    Caragounis, Eva-Corina
    Choi, Jeff
    Christie, D. Benjamin, III
    Cole, Peter A.
    DeVoe, William B.
    Doben, Andrew R.
    Eriksson, Evert A.
    Forrester, Joseph D.
    Fraser, Douglas R.
    Gontarz, Brendan
    Hardman, Claire
    Hyatt, Daniel G.
    Kaye, Adam J.
    Ko, Huan-Jang
    Leasia, Kiara N.
    Leon, Stuart
    Marasco, Silvana F.
    McNickle, Allison G.
    Nowack, Timothy
    Ogunleye, Temi D.
    Priya, Prakash
    Richman, Aaron P.
    Schlanser, Victoria
    Semon, Gregory R.
    Su, Ying-Hao
    Verhofstad, Michael H. J.
    Whitis, Julie
    Pieracci, Fredric M.
    Wijffels, Mathieu M. E.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2021, 90 (03): : 492 - 500
  • [12] A randomized clinical trial of single dose liposomal bupivacaine versus indwelling analgesic catheter in patients undergoing surgical stabilization of rib fractures
    Leasia, Kiara N.
    Ciarallo, Christopher
    Prins, Jonne T. H.
    Preslaski, Candice
    Perkins-Pride, Elizabeth
    Hardin, Kimberly
    Cralley, Alexis
    Burlew, Clay Cothren
    Coleman, Jamie J.
    Cohen, Mitchell J.
    Lawless, Ryan
    Platnick, K. Barry
    Moore, Ernest E.
    Pieracci, Fredric M.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2021, 91 (05): : 872 - 878
  • [13] Surgical stabilization of rib fracture patients versus nonoperative controls treated by a multidisciplinary team in a single institution
    Bauer, Frank
    Haag, Susan
    Najafi, Kaveh
    Miller, Brian
    Kepros, John
    HELIYON, 2023, 9 (04)
  • [14] Prospective single-center paradigm shift of surgical stabilization of rib fractures with decreased length of stay and operative time with an intrathoracic approach
    Tay-Lasso, Erika
    Alaniz, Leonardo
    Grant, William
    Hovis, Gabrielle
    Frank, Madelyn
    Kincaid, Colin
    Brynn, Sargent
    Pieracci, Fredric M.
    Nahmias, Jeffry
    Barrios, Cristobal
    Rockne, Wendy
    Chin, Theresa
    Swentek, Lourdes
    Schubl, Sebastian D.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2023, 94 (04): : 567 - 572
  • [15] Early Outcomes of Surgical Stabilisation of Traumatic Rib Fractures: Single-Center Review With a Real-World Evidence Perspective
    Sedaghat, Negin
    Chiong, Corinna
    Tjahjono, Richard
    Hsu, Jeremy
    JOURNAL OF SURGICAL RESEARCH, 2021, 264 : 222 - 229
  • [16] Comparative study of wound outcomes and surgical strategies: Internal fixation versus external stabilization in rib fracture patients with traumatic chest wounds
    Wang, Dongdong
    Wang, Xiaoqi
    Wang, Qingqing
    Xu, Yueping
    Xu, Yongdong
    INTERNATIONAL WOUND JOURNAL, 2024, 21 (04)
  • [17] CLINICAL AND PROGNOSTIC FEATURES OF ESSENTIAL THROMBOCYTHEMIA: COMPARISON OF WHO 2001 VERSUS WHO 2008/2016 CRITERIA IN A LARGE SINGLE CENTER COHORT
    Ranieri, S. Chiatamone
    Arleo, M. A.
    Trasarti, S.
    Bizzoni, L.
    Carmosino, I.
    De Luca, M. L.
    Mohamed, S.
    Mariggio, E.
    Scalzulli, E.
    De Benedittis, D.
    Colafigli, G.
    Molica, M.
    Rizzo, L.
    Ferretti, A.
    Baldacci, E.
    Mancini, M.
    Santoro, C.
    Breccia, M.
    Vignetti, M.
    Latagliata, R.
    HAEMATOLOGICA, 2019, 104 : 123 - 123
  • [18] Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort
    Ricci, Sofia Chiatamone
    Arleo, Maria Antonietta
    Trasarti, Stefania
    Santoro, Cristina
    Breccia, Massimo
    Bizzoni, Luisa
    Carmosino, Ida
    Mancini, Marco
    Baldacci, Erminia
    Molica, Matteo
    De Benedittis, Daniela
    Ciotti, Giulia
    Mariggio, Elena
    Mohamed, Sara
    De Luca, Maria Lucia
    Pistilli, Giacinta
    Mancuso, Annalisa
    Lisi, Chiara
    Diverio, Daniela
    Vignetti, Marco
    Foa, Robin
    Latagliata, Roberto
    Ferretti, Antonietta
    BLOOD, 2018, 132
  • [19] Does surgical fixation improve pain and quality of life in patients with non-flail rib fractures? A best evidence topic review
    Raza, Samad
    Eckhaus, Jazmin
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 35 (03)
  • [20] Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort
    Ranieri, Sofia Chiatamone
    Arleo, Maria Antonietta
    Trasarti, Stefania
    Bizzoni, Luisa
    Carmosino, Ida
    De Luca, Maria Lucia
    Mohamed, Sara
    Mariggio, Elena
    Scalzulli, Emilia
    Rosati, Serena
    De Benedittis, Daniela
    Colafigli, Gioia
    Pepe, Sara
    Molica, Matteo
    Scamuffa, Maria Cristina
    Di Prima, Alessio
    Ferretti, Antonietta
    Baldacci, Emilia
    Mancini, Marco
    Santoro, Cristina
    Vignetti, Marco
    Breccia, Massimo
    Latagliata, Roberto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E328 - E333